Claims for Patent: 11,110,151

✉ Email this page to a colleague

Summary for Patent: 11,110,151

Title:	''
Abstract:	''
Inventor(s):	''
Assignee:	''
Application Number:
Patent Claims:

Details for Patent 11,110,151

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	June 07, 2000	11,110,151
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	January 19, 2001	11,110,151
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	April 23, 2004	11,110,151
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	October 31, 2013	11,110,151
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	April 20, 2000	11,110,151
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	April 25, 2007	11,110,151
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.